STERIS plc (NYSE:STE) to Post Q1 2025 Earnings of $2.07 Per Share, Zacks Research Forecasts

STERIS plc (NYSE:STEFree Report) – Analysts at Zacks Research reduced their Q1 2025 EPS estimates for shares of STERIS in a research note issued to investors on Wednesday, May 29th. Zacks Research analyst R. Department now expects that the medical equipment provider will earn $2.07 per share for the quarter, down from their previous forecast of $2.16. The consensus estimate for STERIS’s current full-year earnings is $9.12 per share. Zacks Research also issued estimates for STERIS’s Q2 2025 earnings at $2.31 EPS, Q3 2025 earnings at $2.47 EPS, Q4 2025 earnings at $2.72 EPS, FY2025 earnings at $9.58 EPS, Q1 2026 earnings at $2.33 EPS, Q3 2026 earnings at $2.35 EPS and FY2026 earnings at $10.33 EPS.

A number of other brokerages have also issued reports on STE. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, May 10th. Stephens reiterated an “overweight” rating and set a $250.00 price target on shares of STERIS in a report on Friday, February 9th. StockNews.com cut shares of STERIS from a “buy” rating to a “hold” rating in a research note on Thursday. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, May 9th. Finally, KeyCorp started coverage on STERIS in a research report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price target on the stock. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $241.60.

Check Out Our Latest Stock Analysis on STERIS

STERIS Price Performance

STERIS stock opened at $223.24 on Thursday. The company has a market capitalization of $22.06 billion, a PE ratio of 58.44 and a beta of 0.81. The company has a current ratio of 3.06, a quick ratio of 2.34 and a debt-to-equity ratio of 0.49. The stock has a 50-day moving average price of $216.50 and a two-hundred day moving average price of $217.98. STERIS has a 12 month low of $195.47 and a 12 month high of $254.00.

STERIS (NYSE:STEGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.41 by $0.17. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.41 billion. STERIS had a return on equity of 13.73% and a net margin of 6.95%. STERIS’s revenue was up 10.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.30 EPS.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 12th will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a yield of 0.93%. STERIS’s dividend payout ratio (DPR) is currently 54.45%.

Insiders Place Their Bets

In related news, SVP Cary L. Majors sold 2,024 shares of the company’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $232.13, for a total transaction of $469,831.12. Following the sale, the senior vice president now owns 11,369 shares in the company, valued at approximately $2,639,085.97. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, SVP Cary L. Majors sold 2,024 shares of STERIS stock in a transaction on Monday, May 13th. The shares were sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares in the company, valued at approximately $2,639,085.97. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Renato Tamaro sold 1,154 shares of STERIS stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $231.64, for a total transaction of $267,312.56. Following the completion of the sale, the vice president now owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,762 shares of company stock worth $1,798,477. Company insiders own 0.95% of the company’s stock.

Institutional Trading of STERIS

Hedge funds have recently modified their holdings of the stock. Catalyst Capital Advisors LLC acquired a new stake in STERIS in the 3rd quarter valued at $25,000. First Personal Financial Services acquired a new stake in STERIS in the 1st quarter valued at $25,000. J.Safra Asset Management Corp grew its position in STERIS by 77.9% in the 1st quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock valued at $27,000 after purchasing an additional 53 shares during the period. Quent Capital LLC grew its position in STERIS by 112.7% in the 1st quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 71 shares during the period. Finally, VisionPoint Advisory Group LLC acquired a new stake in STERIS in the 4th quarter valued at $34,000. Institutional investors own 94.69% of the company’s stock.

STERIS Company Profile

(Get Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Read More

Earnings History and Estimates for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.